1. Home
  2. PBHC vs TIL Comparison

PBHC vs TIL Comparison

Compare PBHC & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

HOLD

Current Price

$13.62

Market Cap

80.2M

Sector

Finance

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.57

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBHC
TIL
Founded
1859
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.2M
74.7M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
PBHC
TIL
Price
$13.62
$8.57
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
3.2K
55.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.92%
N/A
EPS Growth
46.25
52.54
EPS
0.47
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$5.67
52 Week High
$17.00
$42.75

Technical Indicators

Market Signals
Indicator
PBHC
TIL
Relative Strength Index (RSI) 49.51 52.04
Support Level $13.43 $6.85
Resistance Level $13.75 $9.81
Average True Range (ATR) 0.17 0.68
MACD 0.06 0.03
Stochastic Oscillator 87.40 45.54

Price Performance

Historical Comparison
PBHC
TIL

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: